Clinical trial I3Y-MC-JPBO
A phase II study of Abemaciclib in patients with brain metastases secondary to hormone receptor positive breast cancer, non-small cell lung cancer, or melanoma
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2014-004010-28 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02308020 |
| Inclusion criteria | Brain metastasis |
| Last update |